The verdict
Our read at a glance.
Whether increasing nitric oxide availability improves training performance rather than just the sensation of a pump.
- The signal
- The pharmacology is sound and better than its predecessor: oral citrulline raises plasma arginine more effectively than oral arginine, because it escapes the intestinal and hepatic breakdown that destroys most ingested arginine. Human trials report increases in nitric oxide markers and blood flow. Performance results are more mixed: some studies show increased repetitions to failure and reduced soreness, others show nothing, effect sizes are small, and much of the positive work used citrulline malate, where malate may contribute independently. Registered trials continue across exercise, vascular and clinical settings, including in conditions where nitric oxide availability is genuinely impaired.
- The unknown
- Whether the effect in trained healthy people is real at typical doses, and how much of the positive literature reflects malate rather than citrulline.
- Our read
- Real pharmacology, honest but small performance data, and a sensation that vastly outstrips the measured effect. Feeling a pump is not evidence of anything except vasodilation, which is exactly what it does.
The mechanism
How it works.
Nitric oxide is made from arginine by nitric oxide synthase, and it relaxes vascular smooth muscle, widening vessels and increasing blood flow. Supplementing arginine directly is inefficient because intestinal and hepatic arginase degrade most of it before it reaches circulation. Citrulline bypasses that entirely: it is absorbed intact, taken up by the kidneys, and converted to arginine there, so oral citrulline produces a larger and longer rise in plasma arginine than an equivalent dose of arginine itself. More substrate means more nitric oxide, more vasodilation, and greater delivery of oxygen and nutrients to working muscle - and, incidentally, the visible pump. Citrulline also participates in the urea cycle and may assist ammonia clearance during exercise, which is the usual explanation offered for reduced soreness, though that pathway is less well established than the vascular one.
Safety & regulatory boundary
The consequential part.
A supplement, not an approved drug, and well tolerated. The relevant caution is pharmacological rather than toxicological: it is a vasodilator, so combining it with nitrates or with PDE5 inhibitors taken for blood pressure or pump effects compounds hypotension, and that combination is common in this population.
What's next
What we're watching.
Trials isolating citrulline from malate, which would settle most of the inconsistency.
Context
Why this is discussed.
It is the centrepiece of most pre-workouts, and the vasodilation it produces is immediately perceptible, which makes it unusually convincing.
The evidence base
21 cited references.
Regulatory & labels1
Deseret Biologicals, Inc. (FDA label) · 2024
Registered trials8
ClinicalTrials.gov · NA · ACTIVE_NOT_RECRUITING · 2024-08-09
ClinicalTrials.gov · NA · RECRUITING · 2026-03-20
ClinicalTrials.gov · NA · COMPLETED · 2019-01-17
ClinicalTrials.gov · PHASE1/PHASE2 · RECRUITING · 2015-05
ClinicalTrials.gov · PHASE2 · RECRUITING · 2026-07-22
ClinicalTrials.gov · PHASE2 · RECRUITING · 2026-04-28
ClinicalTrials.gov · PHASE4 · NOT_YET_RECRUITING · 2026-07-01
ClinicalTrials.gov · PHASE2 · RECRUITING · 2026-08-30
Indexed literature (PubMed)12
Gough LA et al. · Eur J Appl Physiol · 2021
Gonzalez AM et al. · J Strength Cond Res · 2020
Iraki J et al. · Sports (Basel) · 2019
Wang X et al. · Nutrients · 2026
Selvaraj S et al. · Sci Rep · 2025
Gonzalez AM et al. · Nutrients · 2023
Devrim-Lanpir A et al. · Nutrients · 2024
Vårvik FT et al. · Int J Sport Nutr Exerc Metab · 2021
Cunniffe B et al. · J Strength Cond Res · 2016
Chowaniec P et al. · Cureus · 2026
Kruszewski M et al. · Nutrients · 2022
Keep reading